0
1. 2. 2024.
Phase 2 Trial of Ruxolitinib Cream for Chronic Cutaneous GvHD
Phase 2 Trial of Ruxolitinib Cream for Chronic Cutaneous GvHD
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više